USMJ brand prominence bolstered by DEA reclassification of CBD

Press Release North American Cannabis Holdings today revealed details regarding an enthusiastic shareholder response to news that the DEA, in cooperation with the FDA, had rescheduled some applications of cannabidiol (CBD) reducing previous restrictions.  The DEA announced yesterday that drugs including “finished dosage formulations” of CBD approved by the FDA containing THC below 0.1 per […]